Europe's regulator to inspect Ranbaxy's India plant in June

MUMBAI Thu Apr 10, 2014 12:48am IST

Related Topics

Stocks

   
Coal Mining In The Punjab

Coal Mining In The Punjab

In Choa Saidan Shah miners dig coal with crude pick axes and load it onto donkeys to be transported to the surface earning a team of 4 workers around $10 to be split between them.  Slideshow 

MUMBAI (Reuters) - Europe's drug regulator said on Wednesday an inspection of Indian generic drugmaker Ranbaxy Laboratories Ltd's(RANB.NS) Dewas plant in India is planned for June, amid concerns about its production processes after a spate of regulatory sanctions.

Ranbaxy, which owner Japan's Daiichi Sankyo Ltd (4568.T) agreed to sell it to Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion on Monday, suspended production at the Dewas plant in February to examine processes.

The company's voluntary suspension at Dewas and another plant in Toansa in the northern Punjab state in February, came after a spate of sanctions against it by the U.S. Food and Drug Administration (FDA) due to poor manufacturing processes.

Ranbaxy informed authorities in the European Union that its internal investigation revealed the Dewas site failed some so-called good manufacturing practices, the European Medicines Agency (EMA) said in a statement issued to Reuters.

A Ranbaxy spokesman did not immediately respond to requests for comment on the EMA statement.

Imports from Dewas had already been banned by the FDA back in 2008 after the agency found violations of drug manufacturing standards there. The FDA has also banned shipments from the three other Ranbaxy plants in India.

(Reporting by Zeba Siddiqui; Editing by Sumeet Chatterjee and Elaine Hardcastle)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

HCL Tech Results

HCL Tech Results

Q4 dollar revenue disappoints investors, shares fall  Full Article 

Fed Policy

Fed Policy

Fed presses forward with bond buying, cites uptick in inflation.  Full Article 

Q2 Profit Slips

Q2 Profit Slips

Samsung sees tough second half  Full Article 

Chinese Economy

Chinese Economy

China should set lower 2015 GDP growth target of 6.5-7 percent - IMF  Full Article 

Default Imminent

Default Imminent

Argentina fails to reach debt agreement   Full Article 

Economy Reboots

Economy Reboots

U.S. economy back on track with strong second-quarter rebound  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage